Ikano Therapeutics

Ikano Therapeutics

Developing digital health tools to help researchers track patient data, analyze it, and export it for publication.

Launch date
Market cap
-
Enterprise valuation
$72—108m (Dealroom.co estimates Mar 2009.)
Saddle Brook New Jersey (HQ)
  • Edit
DateInvestorsAmountRound
-

N/A

-

N/A

Early VC
N/A

$3.1m

Series A

$18.0m

Series B
Total Funding$21.1m

Recent News about Ikano Therapeutics

Edit

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.